---
title: "Plasma Metabolomic Differences Linked to Resistance to Mycobacterium tuberculosis Infection"
id: "medrxiv-20-metabolic-signatures-of-resistance-to-mycobacterium-tuberculosis-infection"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-20-metabolic-signatures-of-resistance-to-mycobacterium-tuberculosis-infection"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.29.26364337v1?rss=1"
published_at: "2026-10-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Plasma Metabolomic Differences Linked to Resistance to Mycobacterium tuberculosis Infection
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-20-metabolic-signatures-of-resistance-to-mycobacterium-tuberculosis-infection
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.29.26364337v1?rss=1)
- **Published At:** 2026-10-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Tuberculosis remains the leading infectious cause of death globally; some heavily exposed individuals remain persistently TST/IGRA-negative and are described as **TB resisters**. - The study applied untargeted high-resolution plasma **metabolomics** (liquid chromatography–mass spectrometry) to compare 269 TB resisters and 269 matched Mtb-infected close contacts enrolled across Brazil, India, and South Africa. - TB resisters were defined as highly exposed household or close contacts (slept in same room or ≥5 hours indoors per day with an infectious pulmonary TB index patient) who remained TST/IGRA-negative; Mtb-infected contacts were TST/IGRA positive. - Metabolome-wide association studies using paired t-tests identified 1,787 features with nominal differences (p < 0.05) between groups. - Pathway enrichment in the overall cohort highlighted **fructose and mannose metabolism** and **bile acid biosynthesis**; in Brazil, lipid-related pathways were enriched. - Among metabolites with confirmed chemical identities and an FDR threshold of 0.2, TB resisters had higher **glyceric acid** (+0.53 μM) and lower **hydroxyproline** (−0.90 μM), **butyrobetaine** (−0.06 μM), and **homogentisate** (−0.0036 μM) compared with matched Mtb-infected contacts. - The authors conclude that systemic plasma metabolic profiles differ between TB resisters and Mtb-infected close contacts, suggesting metabolic signatures associated with resistance to infection. - The study is a preprint and not peer-reviewed; deidentified participant-level data are not publicly available due to consent and IRB restrictions, but summary metabolomics results are in the Supplementary Materials. - The research received ethical approvals from multiple institutional review boards across participating institutions; funders included the US NIH NIAID and several institutional centers.
## Clinical Analysis & Structured Key Points
Metabolic Signatures of Resistance to Mycobacterium Tuberculosis Infection: Insights from a Multi-Country Plasma Metabolomics Study | medRxiv Skip to main content Metabolic Signatures of Resistance to Mycobacterium Tuberculosis Infection: Insights from a Multi-Country Plasma Metabolomics Study View ORCID Profile Chang Liu , Jeffrey M. Collins , Matheus Fernandes Gyorfy , Mariana Araujo Pereira , Vidya Mave , Senbagavalli Prakash , Kamakshi Prudhula Devalraju , Neil A. Martinson , Fay Willis , Marina C Figueiredo , Marcelo Cordeiro-Santos , Artur Trancoso Lopo de Queiroz , Venkata Sanjeev Kumar Neela , Rajesh Karyakarte , Timothy R Sterling , Jerrold J. Ellner , James C.M. Brust , Amita Gupta , Bruno B Andrade , View ORCID Profile Yan V. Sun , Neel R. Gandhi , TB GWAS collaboration doi: https://doi.org/10.64898/2026.09.29.26364337 Chang Liu 1 Emory University School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Chang Liu Jeffrey M. Collins 2 Emory University School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Matheus Fernandes Gyorfy 3 Emory University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mariana Araujo Pereira 4 Fundacao Oswaldo Cruz; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Vidya Mave 5 Johns Hopkins University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Senbagavalli Prakash 6 Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kamakshi Prudhula Devalraju 7 Bhagwan Mahavir Medical Research Centre, Hyderabad, India; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Neil A. Martinson 8 Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Fay Willis 3 Emory University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marina C Figueiredo 9 Vanderbilt University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marcelo Cordeiro-Santos 10 Universidade do Estado do Amazonas, Manaus, Brazil; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Artur Trancoso Lopo de Queiroz 11 Laboratorio de Pesquisa Clinica e Translacional, Instituto Goncalo Moniz, Fundacao Oswaldo Cruz, Salvador, Brazil; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Venkata Sanjeev Kumar Neela 7 Bhagwan Mahavir Medical Research Centre, Hyderabad, India; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rajesh Karyakarte 12 BJ Government Medical College, Pune; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Timothy R Sterling 13 Vanderbilt University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jerrold J. Ellner 14 Department of Medicine, Division of Infectious Diseases, Rutgers New Jersey Medical School, Rutgers Health, Newark, New Jersey, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site James C.M. Brust 15 Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, NY, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amita Gupta 16 Johns Hopkins School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bruno B Andrade 17 FIOCRUZ Bahia: Instituto Goncalo Moniz Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yan V. Sun 3 Emory University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Yan V. Sun For correspondence: yan.v.sun{at}emory.edu Neel R. Gandhi 1 Emory University School of Public Health; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Tuberculosis (TB) remains the leading infectious disease cause of mortality worldwide. A subset of individuals exposed to Mycobacterium tuberculosis (Mtb) remain TST/IGRA-negative despite sustained exposure, termed "TB resisters". The biological mechanisms underlying this resistance remain poorly understood. We applied untargeted high-resolution metabolomics to determine whether systemic metabolic profiles differ between TB resisters and matched Mtb-infected close contacts. Methods: We compared untargeted high-resolution plasma metabolomics using liquid chromatography mass spectrometry between 269 TB resisters and 269 matched Mtb-infected close contacts, enrolled across Brazil, India, and South Africa. TB resisters were defined as highly exposed close contacts who slept in the same room or spent at least 5 hours indoors per day with an infectious pulmonary TB index patient, but remained TST/IGRA-negative. Mtb-infected close contacts were those who were TST/IGRA positive. Metabolome-wide association studies (MWAS) were conducted using paired t-tests. Results: There were 1,787 features with nominal differences between TB resisters and matched Mtb-infected contacts (p < 0.05). Pathway enrichment identified fructose and mannose metabolism and bile acid biosynthesis in the overall cohort, while lipid-related pathways were enriched in Brazil. Among metabolites with confirmed chemical identities, glyceric acid concentrations were higher in TB resisters by 0.53 uM, whereas hydroxyproline was lower by 0.90 uM, butyrobetaine was lower by 0.06 uM, and homogentisate was lower by 0.0036 uM at false discovery rate of 0.2. Conclusions: Plasma metabolomic profiles differed between TB resisters and matched Mtb-infected close contacts. These findings indicate that systemic metabolic differences are associated with resistance to Mtb infection. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by the institutional review boards at the following institutions: Emory University, Johns Hopkins University, Vanderbilt University, Rutgers University, Commisao Nacional De Etica em Pesquisa (CONEP), University of Witswatersrand, Byramjee Jeejeebhoy Government Medical College, Jawaharlal Institute of Postgraduate Medical Education and Research, Bhagwan Mahavir Medical Research Centre, and National Institute for Research in Tuberculosis (Chennai). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Deidentified participant-level data are not publicly available because of participant consent, institutional review board requirements, and data-use restrictions across the participating cohorts. Requests for access may be submitted to the corresponding author and will be considered by the relevant study investigators and institutions, subject to applicable approvals and data-use agreements. Summary-level metabolomics results are provided in the Supplementary Materials. Funder Information Declared US National Institutes of Health-National Institute of Allergy and Infectious Disease , R01AI139406 , K24AI114444 , K24AI155045 , K24AI165099 Emory/Georgia Tuberculosis Research Advancement Center (TRAC) , P30AI168386 Einstein-Rockefeller-CUNY Center for AIDS Research , P30AI124414 Einstein/Montefiore Institute for Clinical and Translational Research , UL1TR001073 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted October 05, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Metabolic Signatures of Resistance to Mycobacterium Tuberculosis Infection: Insights from a Multi-Country Plasma Metabolomics Study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Metabolic Signatures of Resistance to Mycobacterium Tuberculosis Infection: Insights from a Multi-Country Plasma Metabolomics Study Chang Liu , Jeffrey M. Collins , Matheus Fernandes Gyorfy , Mariana Araujo Pereira , Vidya Mave , Senbagavalli Prakash , Kamakshi Prudhula Devalraju , Neil A. Martinson , Fay Willis , Marina C Figueiredo , Marcelo Cordeiro-Santos , Artur Trancoso Lopo de Queiroz , Venkata Sanjeev Kumar Neela , Rajesh Karyakarte , Timothy R Sterling , Jerrold J. Ellner , James C.M. Brust , Amita Gupta , Bruno B Andrade , Yan V. Sun , Neel R. Gandhi , TB GWAS collaboration medRxiv 2026.09.29.26364337; doi: https://doi.org/10.64898/2026.09.29.26364337 Share This Article: Copy Citation Tools Metabolic Signatures of Resistance to Mycobacterium Tuberculosis Infection: Insights from a Multi-Country Plasma Metabolomics Study Chang Liu , Jeffrey M. Collins , Matheus Fernandes Gyorfy , Mariana Araujo Pereira , Vidya Mave , Senbagavalli Prakash , Kamakshi Prudhula Devalraju , Neil A. Martinson , Fay Willis , Marina C Figueiredo , Marcelo Cordeiro-Santos , Artur Trancoso Lopo de Queiroz , Venkata Sanjeev Kumar Neela , Rajesh Karyakarte , Timothy R Sterling , Jerrold J. Ellner , James C.M. Brust , Amita Gupta , Bruno B Andrade , Yan V. Sun , Neel R. Gandhi , TB GWAS collaboration medRxiv 2026.09.29.26364337; doi: https://doi.org/10.64898/2026.09.29.26364337 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (626) Allergy and Immunology (913) Anesthesia (340) Cardiovascular Medicine (4884) Dentistry and Oral Medicine (485) Dermatology (421) Emergency Medicine (659) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1643) Epidemiology (16062) Forensic Medicine (34) Gastroenterology (1218) Genetic and Genomic Medicine (7127) Geriatric Medicine (736) Health Economics (1072) Health Informatics (5121) Health Policy (1447) Health Systems and Quality Improvement (1792) Hematology (589) HIV/AIDS (1355) Infectious Diseases (except HIV/AIDS) (16353) Intensive Care and Critical Care Medicine (1184) Medical Education (678) Medical Ethics (156) Nephrology (729) Neurology (7382) Nursing (370) Nutrition (1102) Obstetrics and Gynecology (1263) Occupational and Environmental Health (1010) Oncology (3656) Ophthalmology (1066) Orthopedics (399) Otolaryngology (459) Pain Medicine (483) Palliative Medicine (142) Pathology (711) Pediatrics (1821) Pharmacology and Therapeutics (741) Primary Care Research (776) Psychiatry and Clinical Psychology (5985) Public and Global Health (9833) Radiology and Imaging (2462) Rehabilitation Medicine and Physical Therapy (1478) Respiratory Medicine (1256) Rheumatology (650) Sexual and Reproductive Health (785) Sports Medicine (588) Surgery (786) Toxicology (107) Transplantation (310) Urology (298)
## Related Clinical Research

- [Self-reported tuberculosis prevalence and vulnerability factors in six rural Indian districts](https://medichelpline.com/clinical-feed/plos-one-16-self-reported-prevalence-of-tuberculosis-and-selected-associated-vulnerability.md)
- [Parenchymal Neuro-Behçet Disease Case Report: Heterogeneous Clinical Presentations](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-parenchymal-neuro-beh-et-disease-with-heterogeneous-clinical-presentations-a.md)
- [Multimorbidity with tuberculosis in Kampala: prevalence, care gaps and impact on outcomes](https://medichelpline.com/clinical-feed/medrxiv-1-multimorbidity-in-tuberculosis-and-its-impact-on-health-and-treatment-outcomes.md)
- [Temporal patterns of tuberculosis-associated hyperglycaemia and effects on treatment outcomes in n](https://medichelpline.com/clinical-feed/plos-one-0-temporal-patterns-of-tuberculosis-associated-hyperglycaemia-and-its-effect-on.md)
- [Nine-month all-oral regimen for MDR/RR-TB in Lesotho: safety and effectiveness by HIV status](https://medichelpline.com/clinical-feed/medrxiv-7-nine-month-all-oral-regimen-for-mdr-rr-tb-in-lesotho-safety-and-effectiveness.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.